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From metagenomics to the metagenome: Conceptual change and the 
rhetoric of translational genomic research 
 
ERIC JUENGST AND JOHN HUSS1 
Abstract  
As the international genomic research community moves from the tool-making efforts of 
the Human Genome Project into biomedical applications of those tools, new metaphors 
are being suggested as useful to understanding how our genes work – and for 
understanding who we are as biological organisms. In this essay we focus on the Human 
Microbiome Project as one such translational initiative. The HMP is a new 
‘metagenomic’ research effort to sequence the genomes of human microbiological flora, 
in order to pursue the interesting hypothesis that our ‘microbiome’ plays a vital and 
interactive role with our human genome in normal human physiology. Rather than 
describing the human genome as the ‘blueprint’ for human nature, the promoters of the 
HMP stress the ways in which our primate lineage DNA is interdependent with the 
genomes of our microbiological flora. They argue that the human body should be 
understood as an ecosystem with multiple ecological niches and habitats in which a 
variety of cellular species collaborate and compete, and that human beings should be 
understood as ‘superorganisms’ that incorporate multiple symbiotic cell species into a 
single individual with very blurry boundaries. These metaphors carry interesting 
philosophical messages, but their inspiration is not entirely ideological. Instead, part of 
their cachet within genome science stems from the ways in which they are rooted in 
genomic research techniques, in what philosophers of science have called a ‘tools-to-
theory’ heuristic. Their emergence within genome science illustrates the complexity of 
conceptual change in translational research, by showing how it reflects both aspirational 
and methodological influences.  
Introduction 
“Thus, it seems appropriate to consider ourselves as a composite of many species — 
human, bacterial, and archaeal – and our genome as an amalgam of human genes 
and the genes of our microbial ‘selves’.” 2 
 
“Step forward into the world of metagenomics and we start to see ourselves as supra-
organisms whose genome evolved with associated microbial genomes (the 
microbiome).” 3  
 
“This study supports the theory that we are in fact ‘superorganisms’ whose 
metabolism integrates microbial and human features.”4  
 
“We are superorganisms,” or so claims virtually any scientific paper one might pick 
up on the Human Microbiome Project (HMP) and its implications for medicine. In 
some ways this holist language is quite surprising. After all, metagenomics – a suite 
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of methods for bulk sequencing the microbial DNA in environmental samples – 
would at first glance appear to be the epitome of reductionism: it ignores as noise 
everything but molecular genomic information in seeking to solve biological 
problems . Moreover, the progenitor of the HMP, the Human Genome Project, was 
famous for its essentialistic promotional metaphors,5,6 and even today many 
interested in “translating” genomic science into practical applications depend on 
rhetoric that reduces human identity to our genes.7 So how is it that the holist co
of the superorganism, with all its spatial and causal indeterminacies, has become 
ubiquitous as scientists seek to apply genomics to medical subdisciplines like 
gastroenterology an
ncept 
d dermatology?  
 
In this essay, we suggest three explanations that emerge from a close reading of the 
HMP literature, as hypotheses for further empirical research. The first is the social 
influence of new scientific partners. Microbial ecologists and microbiologists of the 
gastrointestinal tract have long held that the human microbiota – the set of microbes 
that live in and on us – play an important role in human health, at least as important as 
that of our ‘human’ cells. By embracing genomic approaches, these scientists gain a 
powerful platform for promoting their conceptual framework as an antidote to the 
essentialism of the Human Genome Project. Moreover, the microbiologists’ 
ecological thought-style is attractive to the human genomics community, because it 
provides the concepts they need in order to address their political obligation to 
translate genome science into clinical health care benefits. Simply put, one way to 
make the (famously inaccessible) human genome more manipulable for therapeutic 
ends is to redefine it to include elements we can manipulate, and by doing so genomic 
research can live up to its “translational” promise to repay public investments with 
health benefits. Neither of these first two factors are surprising sources of rhetorical 
innovation, given what science studies teaches us about the role of political and social 
forces in scientific conceptual change. The third, however, is of more potential 
interest, especially for those concerned with the role of metaphor in science. This is 
the influence of what philosophers of science call the ‘tools-to-theory’ heuristic: i.e., 
the ways in which the techniques and operational strategies of a science can serve as 
models for the phenomena it describes. In this case, metagenomic sequencing tools 
designed to address ecologically-framed questions have generated a new theoretical 
entity for genomics – the ‘metagenome’. Cumulatively, these three influences expand 
the HMP scientists’ rhetorical repertoire, significantly changing the metaphors for 
health, disease, and human nature that they use to articulate the meaning of their 
work. 
DNA sequencing as a ‘platform technology” for human microbial ecology 
Forty years before the HMP, gastroenterology was revolutionized by the 
reconceptualization of the human gut as an ecosystem and the application of field 
ecology theories to the study of gut microbiota.8 It became standard, for example, to 
classify microbial species in the gut as indigenous on non-indigenous (or 
allochothonus) members of a ‘community’ occupying a given “habitat” within the gut, 
to describe the factors that governed successful microbial ‘colonization’ of the lumen 
and mucosa in the newborn, and to talk about the “ecological succession to a climax 
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community” of gut microbiota in the human adult.9 This paradigm allowed medical 
microbiologists to connect their work with that of their colleagues in soil and water 
microbiology to create “microbial ecology” as a robust field that shares tools and 
concepts across widely disparate domains.10  
 
One of the core problems for this research program in gastroenterology has been 
distinguishing indigenous from alien microbial species. To do so was important since 
the assumption was that in a well-functioning gastrointestinal ecosystem, each habitat 
is inhabited by a community of one or more indigenous microbial species. When the 
ecosystem has been perturbed and a habitat has been vacated by its native species, 
alien species may colonize the vacated habitat – the system is ‘out of balance’. In such 
cases, it would be easy for someone studying the system to think that allochothonus 
species, because they do occupy a niche, are indigenous. As a result, the central tasks 
for those studying the microbial ecology of the human gastrointestinal tract have been 
to identify the various habitats, describe the taxonomic composition of the 
communities that occupy each of these habitats and unravel the interactions between 
the species in the community and their host both in the climax community and in the 
successional stages leading up to it. Traditionally, the biggest hurdles in this effort 
have been sampling the innermost recesses of the intestines and culturing anaerobic 
bacteria and archaea in vitro. Despite improvements in selective culturing techniques, 
culturing bacteria and archaea is a painstaking process, and for many communities of 
interest, the vast majority of microbial ‘species’ have not been cultured, thus 
hampering the abilities of microbial ecologists to model the precise contributions of 
various microbial taxa to the ecological dynamics and trophic exchanges of the 
particular microbial ecosystem under study.11 
  
While human bacteria like E. coli were, as “model organisms,” the test beds for the 
development of the DNA mapping and sequencing techniques used by the Human 
Genome Project, the real applications for genomics in addressing the microbiologists’ 
problems came from the environmental side of the field, where DNA sequencing 
techniques were applied to undifferentiated soil and water samples in order to identify 
all the microorganisms involved and study their molecular interactions.12 This was 
called “metagenomic” analysis, simply to indicate that mixed samples of genomes 
from multiple species were being analyzed. Metagenomic methods bypass the 
problems of anaerobic bacterial sampling and culturing by simply extracting the DNA 
en masse from all of the microbes present in an environmental sample like a cubic 
inch of soil, water, or stool. From there fragments of the environmentally sampled 
DNA can be inserted (or ‘cloned’) into vectors, such as Bacterial Artificial 
Chromosomes (BACs), fosmids, or plasmids. Laboratory bacteria (such as E. coli) can 
be manipulated to serve as hosts for these vectors. When these laboratory bacteria 
divide, they replicate not only their own ancestral DNA but also that contained in the 
vectors. When the set of laboratory host bacteria encompasses all of the DNA 
sequence extracted from the environmental sample, it is called a DNA library of the 
sampled microbial community.13  
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Once a metagenomic DNA library has been obtained there are two general sets of 
methods to study it: sequence-based and function-based. Sequence-based methods are 
generally concerned with the question: who’s there? In sequence-based 
metagenomics, the focus is on identifying contiguous sequences, often with the 
intention of putting the pieces together to identify the bacterial ‘species’ present in the 
sample. Alternatively, the goal may simply be to document the genetic diversity of the 
sample, often for purposes of intercommunity comparison. In function-based 
metagenomics, the focus is on translating all the random bits of DNA into proteins 
and screening them for enzymatic activity and other capabilities such as antibiotic 
resistance and vitamin synthesis.14  
 
The ability of metagenomic strategies to bypass the traditional bottlenecks in the 
microbial ecology research program has made bulk DNA sequencing an indispensable 
‘platform technology’ for that field, both for illuminating microbial community 
composition and for insights into function that knowledge of gene products provides. 
The promise and proliferation of these techniques beyond gut microbiology to studies 
of the microbial flora of different regions of the human epidermis, teeth, hair, ears, 
pharynx, and genito-urinary tracts made it possible to advance the idea of a 
comprehensive “human microbiome project” that would use genomic tools to study 
the entire human body as an ecological biome for microbiota.15  
 
At the same time, metagenomic sequencing also provided microbial ecologists with 
another kind of platform as well: a podium from which to introduce genome scientists 
to their ecological ways of understanding the human body. Almost every article 
promoting the HMP takes care to point out that “The gastrointestinal tract can be 
regarded as a very complex ecosystem, because it does not involve solely eukaryotic 
tissues like in other organs, but involves interplay between food, host cells and 
microbes."16 On this construction, the body’s bacteria are not adventitious parasites, 
but participating species in an ecosystem that can benefit both them and their human 
host. Thus, “the microbial ecosystem of the mammalian gastrointestinal tract is in a 
homeostatic relationship with the host’s immune system. As expected for co-evolving 
systems, both microbe and mammal benefit from this symbiotic partnership.”17  
 
To some extent, describing the human body as an ecosystem is meant literally: the 
ecological paradigm in microbiology does make it possible to discern and study 
human microbiota in ways that use the term ecosystem much as it is used in 
environmental sciences. However, it is also evident that there are metaphorical 
ecosystems in play in the HMP promoters’ rhetoric, as when the literature begins 
describing the body in geographical terms, as a landscape. For example, as one 
scientist writes: 
 
When a new human being emerges from its mother, a new island 
pops up in microbial space. Although a human lifespan is a blink in 
evolutionary time, the human island chain has existed for several 
million years, and our ancestors stretch back over the millennia in a 
continuous archipelago.18  
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Like geographical island ecosystems, the human body contains many micro-climates 
and ecological niches across three major zones: its inner lining (the gut), its exterior 
covering (the skin) and its multiple and very different orifices. Microbiomists speak of 
the microbial ‘tide pools’ of the teeth, and the ‘rainforest’ of the gut, using the 
strikingly 19th century language of mapping ‘largely unexplored’ terrain, populated by 
‘indigenous’ species of bacteria.19 As the proponents of the HMP say, “Microbes 
thrive on us: we provide wonderfully rich and varied habitats, from our UV-exposed, 
oxic and desiccating skin to our dark, wet, anoxic and energy rich gut that serves as a 
home to the vast majority of our 100 trillion microbial (bacterial and archaeal) 
partners.”20 
 
By slipping from literal to figurative uses of ecological language, the HMP 
proponents set the stage for a very different understanding of the human individual 
than that evoked by traditional genomic metaphors. Far from being ‘read-outs’ or 
projections of their internal DNA ‘blueprints’, human beings are at the very least very 
busy sites of external activity, as biological hosts to hosts of microbiota. Moreover, 
even in the ways in which the term ‘microbiome’ is used in the literature there are 
hints of something more. On one hand, ‘microbiome’ is sometimes used to evoke the 
older ecological term ‘biome’, which historically referred to a major biotic 
community characterized by the dominant forms of plant life and the prevailing 
climate. For example Nicholson and co-workers in their 2005 paper, ‘Gut 
microorganisms, mammalian metabolism and personalized health care’, explicitly 
defined “microbiome” (in their glossary) as “the entourage of associated microflora in 
a host”,21 essentially an association of organisms in an environment. On the other 
hand, the term ‘microbi-ome’ is also very readily assimilated to all of the other ‘omes’ 
that molecular biology has bequeathed us, to wit: the metabolome, proteome, 
transcriptome, and genome. On this conception, the microbi-ome is simply the 
genome of some complement of microbes: the human gut microbi-ome, for example. 
For example, one author writes that: “The collective microbial genome, termed the 
microbiome, has a coding capacity that vastly exceeds that of the human genome and 
encodes biochemical pathways that humans have not evolved.”22 Conceived in this 
way, the human microbi-ome becomes a complementary counterpart to the human 
genome within a larger set of genes that influence human physiology: the human 
‘metagenome’. The equivocation between these two senses of ‘microbiome’ within 
the HMP literature is indicative of more than a translational difficulty between fields: 
as we suggest below, it also signals the reification of metagenome as a molecular 
entity in its own right.  
Discussion: Implications for genetic determinism 
In a recent series of papers, Dupré and O’Malley have argued that metagenomics has 
been helpful in replacing an entity-based view of biology with a process-based 
one.23,24,25 From the point of view of metagenomics, one can begin to think of 
microbial communities not as a collection of interacting unicellular organisms, but as 
multicellular organisms – metaorganisms  – sharing genetic resources through 
different lateral transfer processes, and also engaged in a number of coordinated 
multicellular processes such as quorum-sensing. As Dupré and O’Malley note:  
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A final crucial point about metaorganisms is that they are 
paradigmatically dynamic entities and therefore very clear 
illustrations of the ultimate necessity of a process-oriented approach 
to biological investigation. None of the entities that constitute 
organisms, or which organisms constitute, are static. Genomes, cells, 
and ecosystems are in constant interactive flux: subtly different in 
every iteration, but similar enough to constitute a distinctive 
process.26  
 
If the human genome is also reconceived as merely another component in such an 
ecosystem, this deals an obvious blow to the old genetic determinism. Far from being 
the ‘master molecule’ in our physiology, our nuclear DNA is demoted to simply 
another set of cellular genomes jostling for influence within us, reacting to and being 
regulated by, a set of microbial genomes that outnumber them 10 to one. As Dupré 
and O’Malley point out, “The original human genome sequencing projects were, from 
this perspective, about only a tiny and unrepresentative complement of our genes.”27  
 
This new level of indeterminacy has important implications. First, it has the potential 
to undermine the social risks that a deterministic view exacerbates. If our insurers and 
employers appreciate the causal complexity and power of the metagenome, they may 
be less likely to penalize us for the potential health risks lying dormant in any of its 
parts. More importantly for metagenomics’ status as a “translational” science, 
however, the new causal complexity opens up possibilities for preventing and 
manipulating those health risks. In one interesting picture of the utopia waiting 
beyond the HMP, the project’s proponents manage to capture both these virtues: 
 
Our medical insurance cards will contain one chip for our primate 
genome, and one for our microbiome. As part of the annual physical 
exam, physicians will take a stool sample to update the microbiome 
profile. Just as today a rise in blood pressure from one visit to the 
next signals a risk of developing heart disease, tomorrow changes in 
the microbiome profile will herald a predisposition to diseases such 
as obesity. Therapeutic intervention will follow, likely a combination 
of individualized nutrition, deliberate ‘reprogramming’ of the 
microbiota with addition/removal or stimulation of particular 
lineages or genetic complements within the microbiome, or use of 
microbial gene products themselves (or their revealed human gene 
product targets) as part of our 21st century pharmacopoeia.28 
 
It has been popular amongst genome scientists to cast the ethical, legal, and social 
issues in genome research as time-limited problems caused by the ‘therapeutic gap’ 
between our ability to read people’s genomes and our abilities to offer effective 
remedies to any deficits we find there. As genomic medicine catches up with genome 
science, the argument goes, the issues caused by this awkward interim should 
evaporate, because it will no longer be in anyone’s interests to discriminate on the 
basis of genotype.29 The relatively slow growth of human gene therapy, 
pharmacogenomic interventions, and other forms of personalized genomic medicine 
over the last decade has been discouraging for this line of argument – until now. If 
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interventions as ‘easy and efficient’ as probiotic inoculations of genetically modified 
bacteria can be counted amongst the armoury of personalized genomic medicine, then 
the closing of the therapeutic gap may well be at hand. This would achieve genomics’ 
“translational” ambitions and perhaps relieve ethical, legal and social constrictions in 
the process. 
 
The second implication of the indeterminacy that comes with an ecological view of 
the body is even more encouraging for the genomics community: It suggests an 
increased range of opportunities for therapeutic intervention. This promise is very 
important to the political justification for the public’s investment in genomics as a 
“translational” science, and that drives a need to find ways to appropriate the 
microbial ecologists’ view for human genomics. In the HMP literature, this takes the 
form of stressing the interdependence between human individuals’ ‘primate lineage’ 
genomes and the genes of the microbiota we host, which forms the next step towards 
the ‘superorganism’ concept. 
Translational genomic research and the clinical imperative 
After floundering with the infelicity (and inaccuracy) of entering a ‘post-genomic era’, 
the genome research community in the US now universally calls its new phase that of 
‘translational genomic research’, to capture its goal of using genomic science to develop 
specific interventions that can be used in clinical and public health settings to benefit 
human health. The HMP is counted as “translational genomic research” primarily 
because it attempts to use genomic tools to address a problem of medical interest, by 
improving our understanding of the role of bacteria in human physiology and disease. 
One of the challenges that genomics faced before the HMP was that, beyond genetic 
risk testing and pharmacogenomic drug dosage screening, the prospects of using 
genomic knowledge to develop therapeutic interventions in the human genome 
directly were at best remote. If the scope of genomic medicine can be expanded 
beyond our ‘primate lineage’ DNA to the genomes of our microbial flora, however, a 
world of potential clinical manipulations is opened up, making it possible to satisfy 
the political imperative to promise health benefits from the public’s investments in 
genomic science. Ultimately, the proponents hope to be able to provide both 
diagnostic tools, using DNA screening to assess a patient’s bacterial needs, and more 
effective and ‘individualized’ probiotic therapies to address microbial imbalances. 
Genetically engineering the bacteria we include in these therapies could provide a 
useful new avenue for delivering pharmaceuticals and nutrients as well, or even for 
replicating, in a reversible and safer way, what we might attempt to achieve through 
somatic cell gene therapy.  
In order to make this move, however, genomic science needs a conceptual 
justification for annexing what already exists scientifically and commercially as 
clinical microbiology and the practice of ‘probiotic medicine’. Embracing the 
microbiologists’ ecological rhetoric and building on it to recast the human genome as 
a multi-part system is critical to that enterprise. Thus, in its manifesto for the HMP, 
The New Science of Metagenomics, the National Research Council writes: 
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In the end, it may be possible to view ecosystems themselves as 
biological units with their own genetic repertoires and to sidestep 
consideration of individual species. Then, both ‘Who is there?’ and 
‘What are they doing?’ could be replaced with ‘What is being done 
by the community?’30 
 
In order to justify this move, proponents of the HMP must explain the roles that the 
microbiota and the microbiome play as community members in the ecosystem of the 
human body. From a medical point of view, it is particularly important to know how 
they are involved in health and normal physiology, because if they are simply 
parasitic pathogens it is too easy to dismiss them as alien and, thus, outside the pale of 
human genomic science. Thus, the architects of the NIH HMP write in a background 
paper:  
 
As twenty-first century medicine evolves its focus towards disease 
prevention, new and better ways of defining our health status are 
needed. The gut microbiota is an effector and a reporter of many 
aspects of our normal physiology. Comparisons of germ-free and 
colonized animals have shown that the microbiota helps regulate 
energy balance, both by extracting calories from otherwise 
inaccessible components of our diet and by controlling host genes 
that promote storage of the extracted energy in adipocytes (2-4). The 
microbiota directs myriad biotransformations, ranging from 
synthesis of essential vitamins to the metabolism of the xenobiotics 
that we ingest and the lipids that we produce).31 
 
Moreover, as this list indicates, among these interesting microbiotic contributions to 
our physiology are interactions with our ‘primate lineage’ genes. Microbiota help 
regulate differential gene expression in different tissues and in response to 
environmental stimuli, effectively extending the capacity of our cells to differentiate 
and adapt. As humans and their bacteria have co-evolved, this has meant a role for the 
microbiome even in the ‘internally programmed’ process of normal growth and 
development. As Dupré and O’Malley point out in their review:  
 
Particularly striking is the growing understanding that symbiotic 
bacteria are required for the proper development of many 
vertebrates. … In fact, for the majority of mammalian organism 
systems that interact with the external world – the integumentary 
(roughly speaking, the skin), respiratory, excretory, reproductive, 
immune, endocrine, and circulatory systems – there is strong 
evidence for the coevolution of microbial consortia in varying levels 
of functional association.32 
 
The key to the success of this shared system of genetic regulation is the wide variation 
that bacterial genomic plasticity provides, which allows the microbial lineages in our 
metagenome to evolve quickly in the face of selective pressures. As the National 
Research Council report explains, “The mechanisms for rearranging coding elements 
within a genome serve as mutational switches, ensuring that as the environment 
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changes due to shifts in chemical, physical or biological conditions, there will be 
variants in the cell population that can flourish.”33 
 
As our microbial genome evolves under environmental pressure, in other words, so do 
the messages that it conveys to the human genome, affecting the expression, 
regulation and replication of our primate genes.34 
 
By stressing this functional and evolutionary interdependence, proponents of the HMP 
can begin to cast the human and the microbial genomes as complementary elements of 
the same genomic system, both of which must be included in any adequate 
‘translational’ account of human genomics. For example, Blaser writes:  
 
The first human genome project has been completed. It is now time 
to invest in a second human genome project: sequencing the 
cumulative genomes of our microbiota. This is likely to uncover 
more indicator organisms, the presence or absence of which 
indicates important disease trends. Furthermore, harnessing these 
sophisticated host-adapted organisms to do our bidding could 
uncover new medical treatments.35 
 
This is an important point to establish for the proponents of the HMP, because it 
allows them to point out that "although the primate lineage component of the human 
genome is decoded, sequencing of the microbiome is just beginning”,36 and argue in 
favour of a concerted effort to complete it, since: “Without understanding the 
inhabitants of the human microbiome and the mutualistic human-microbial 
interactions that it supports, our portrait of human biology will remain incomplete.”37  
Discussion: Implications for concepts of health and disease 
Advocates of the HMP promise that: 
  
Once these [metagenomic] methods are in hand, the epidemiologist 
of the future can collect metadata to correlate with variability 
between his subject’s microbiomes. The results of epidemiological 
studies will be translated into therapies. Our medical insurance cards 
will contain one chip for our primate genome, and one for our 
microbiome.38 
 
What form those therapies will take, however, will depend on how we frame the 
information contained in those chips. Taking them to reflect the dynamics of an 
integrated, interdependent ecosystem will have implications for both the diagnosis and 
the treatment of human maladies, because of the concepts of health and disease this new 
framework promotes.  
 
Viewing the human body as an ecosystem of co-existing cellular species poses a 
major challenge to the 19th century doctrine of specific causation and the models of 
health and disease it supports. In both Pasteur’s germ theory and Virchow’s cellular 
pathology, diseases were understood to be reducible to real things in the world: the 
pathogens or lesions which could provide necessary and sufficient targets for 
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intervention. Under this view, diseases are separable from the patients that suffer them; 
they are understood best as predators attacking the patient, either as invading germs or as 
devouring wounds. On this model, the proper target for therapeutics is not the 
epiphenomenal clinical symptoms of the disease, but whatever the disease ‘agent’ does 
to cause those symptoms: the infection, the metastasis, or the break. The great successes 
of the public health movement in combating infectious disease in the early 20th century, 
and the reorientation of psychiatry to look for the ‘organic’ bases of mental illness during 
the same period, owe much to this interpretation of disease, as does the common 
correlative view that health is largely a matter of being ‘clean’ and ‘whole’.  
 
If the human body is essentially an ecosystem, however, the notions of ‘purity’, 
‘integrity’ and ‘wholeness’, on one hand, and ‘infection’, ‘contagion’ and ‘corruption’ 
on the other, make little sense, since ecosystems are understood to have fluid 
boundaries and to support multiple species in a cycle of growth, predation and decay. 
As a result, the microbiomists point out, the metaphors of war no long apply so well 
to our understanding of health and disease: 
 
In the face of these challenges, the metaphor of “war” on infectious 
diseases – characterized by the systematic search for the microbial 
“cause” of each disease, followed by the development of 
antimicrobial therapies – can no longer guide biomedical science or 
clinical medicine. A new paradigm is needed that incorporates a 
more realistic and detailed picture of the dynamic interactions 
among and between host organisms and their diverse populations of 
microbes, only a fraction of which act as pathogens.39 
 
Of course, ecosystems can have problems, if they are forced into crises by changing 
contextual conditions. Species can overpopulate, resources evaporate, and 
interdependent processes collapse. 
 
As HMP promoters emphasize: 
 
Any ecosystem needs to be in a state of balance in order to function 
effectively. Disturb one component, and dire consequences to the 
entire system can follow. In nature, ecosystem disruption often 
results in massive death of the constituent species. The ecosystem 
we will focus on in this mini-review is the human gut with its 
extensive and complex flora of microorganisms. The human 
intestine is part of a truly amazing ecosystem that is essential for the 
successful and efficient absorption of nutrients.40 
 
This rhetoric of balance resonates well with the traditional philosophical competition 
for the doctrine of specific causation: the old ideas of Galenic humoral pathology and 
the ‘constitutional pathology’ that followed it at the end of the 19th century. On this 
model, which the microbiomists adopt in ecological form, human health is a matter of 
having one’s physiological processes and predispositions (or dyscrasias) aligned 
correctly to promote homeostasis, so that the body runs as much like a self-regulated 
and self-sustaining system as possible. As Dupré and O’Malley suggest, “Indeed, it 
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may turn out that diseases caused by microbial pathogens are best seen not so much as 
an invasion by a hostile organism, but rather as a kind of holistic dysfunction of the 
microbiome.”41 
 
On this model, there are no diseases in an ontological sense; only sick patients whose 
bodily processes have gone awry in one direction or another. Thus, while infecting 
patients with new germs seems a counter-intuitive form of treatment against the 
doctrine of Specific Causation which gave us antibiotics, repopulating a depleted 
stock of commensal organisms through ‘probiotic’ infusions is entirely plausible 
under this reframing, in just the same way that restocking a habitat with keystone 
species makes sense for environmental preservation. Thus:  
 
Individualized medicine will only become truly individualized when 
all aspects of an individual, human and bacterial alike, can be 
considered. A potential model is emerging, in which a disruption in 
the microbiome results in a functional imbalance, contributing to a 
pathological state (Fig. 1b). Treatments such as drugs, changes in 
diet or re-seeding efforts could facilitate a return to the steady state 
between the human body and resident microbiota, thereby restoring 
the functions of supermetabolism.42 
 
Of course, constitutional pathology also has its constitutional weaknesses from a 
psychosocial point of view, as history has shown us.43 First, if sustaining and 
recovering my health is a matter of controlling the contextual forces that influence my 
inner homeostasis, this means that much more of my health care becomes my own 
responsibility. My physicians (and insurers) cannot and should not be expected to 
police and redress my complete lifestyle. Instead, it is up to me to improve my diet, 
avoid toxic environments, and ensure that my habits are conducive to sustaining a 
healthy microbiosphere. This reallocation of responsibility is both ‘empowering’ for 
the individual, and potentially exculpatory for the social actors who might ordinarily 
bear responsibility for health care.  
 
Moreover, an extension of this shift of responsibility is the form of stigmatization that 
typically accompanies ‘balance’ models of health and disease: the social perception of 
an individual as intrinsically inclined to go awry in specific ways. We already know 
the alcoholic, the presymptomatic victim of Huntington's Disease, and those labeled 
“at risk” by probabilistic genetic testing.44 Now it is possible to be vulnerable to 
disease by sustaining a maladaptive microbiome as well, like the habitual ‘abusers’ of 
antibacterial products who encourage the selection of drug resistance within their 
indigenous flora.  
Finally, as this discussion of health suggests, the metagenomic model also raises 
questions about who is the beneficiary of health or the victim of disease. As the 
microbiomists point out: “In addition to being numerous, our microbes also are 
enormously varied – more than 1,000 bacterial species abound in a variety of niches 
in our bodies. This immediately raises the question of who we are.”45 By reifying the 
microbial ecologists’ instrumental use of bulk sequencing to create the ‘metagenome’ 
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as a biological entity, the proponents of the HMP are able to advance “a 
superorganism” as their answer.  
The “metagenome” and the human superorganism.  
As important as the sociological and political factors are in framing the unusual 
rhetoric of the HMP, its most provocative claims about human nature also have 
important roots in the project’s ‘metagenomic’ methods. The HMP is metagenomic 
because it seeks to do bulk DNA sequencing of multiple bacterial species, like other 
metagenomic research projects. Unlike its predecessors, however, the HMP aspires to 
go further to support studies that include human somatic cell genomes in the 
metagenomic mix, in order to understand our inter-species interactions at the 
molecular level. As the US National Research Council explains in its ringing 
endorsement of the HMP:  
  
The human “metagenome” might be considered an amalgamation of 
the genes contained in the Homo sapiens genome and in the 
microbial communities that colonize the body inside and out. The 
organisms within these communities are collectively known as the 
human “microbiome.” The metagenome of these communities 
encodes physiological traits that humans have not had to evolve, 
including the ability to harvest nutrients and energy from food that 
would otherwise be lost because we lack the necessary digestive 
enzymes. Without understanding the inhabitants of the human 
microbiome and the mutualistic human-microbial interactions that it 
supports, our portrait of human biology will remain incomplete.46 
 
As this quote suggests ,if the architects of the Human Genome Project hoped to 
achieve a “slow but steady conceptual evolution” in biomedicine,47 the proponents of 
the Human Microbiome Project have much grander ambitions: they to seek to spark 
nothing short of Kuhnian scientific revolution in our understanding of human biology. 
They argue that as the “new science” of metagenomics emerges:  
 
Basic ideas that organize biologists’ understanding of the living 
world may need refinement in the face of greater understanding of 
[microbial] community function. New concepts of genomes, species, 
evolution, and ecosystem robustness will have effects beyond the 
specific field of microbiology. The questions that must be asked are 
“deep” ones...48 
 
At so early a stage it is difficult to tell whether the metagenomics revolution 
represents a Kuhnian “paradigm shift” or simply provides researchers with a better set 
of tools with which to work on the traditional problems of microbiology and microbial 
ecology. Interestingly, there is another, non-Kuhnian mechanism of scientific change 
that holds promise for understanding the transition of the metagenomics research 
program from a set of tools to a new ontology and set of concepts: the ‘tools-to-
theories heuristic’. Gigerenzer coined the phrase “tools to theories heuristic” to refer 
to the modelling of theoretical concepts on the very tools and techniques of empirical 
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investigation.49 While new tools are often developed in order to answer old questions 
that had been heretofore recalcitrant, he notes that those same tools often bring with 
them possible new ways of conceiving the phenomenon under study. In Gigerenzer’s 
work on the history of cognitive psychology, he found, for example, that researchers 
using Bayesian statistics to analyze their experimental data on human cognition 
tended to conclude that their research subjects cognized like Bayesians! A less 
extreme form the tools-to-theories heuristic might take is for the knowledge products 
of our empirical tools to become reified as theoretical entities. In the history of 
intelligence research, for example, we can look to Gould’s work on the reification of 
“g” as the factor underlying the concept of a unitary “general intelligence factor”.50 In 
looking at the relatively recent, relatively short history of metagenomic research, it 
appears that a tools-to-theories heuristic may be at work as the techniques of 
metagenomics have given rise to the ‘metagenome’, conceived of as a genomic unit in 
its own right.51  
 
Conceptually converting a research strategy – metagenomic sequencing – into a new 
theoretical entity – the “metagenome” – provides a provocative answer to Blaser’s 
question about “who we are”: biologically, at least, we are not intrinsically 
individuals, but collective “metaorganisms”, assimilating multiple species, millions of 
individual organisms, and billions of genes. As almost every article in this literature 
argues, seeing our bodies as interdependent ecosystems encourages us to find a way to 
incorporate our microbiome into our sense of self. “Thus, it seems appropriate to 
consider ourselves as a composite of many species – human, bacterial, and archaeal – 
and our genome as an amalgam of human genes and the genes of our microbial 
‘selves’.”52 
 
In order to explain this amalgam, the microbiomists borrow from zoology the concept 
of the “superorganism”53 to assert that: “Together with our microbes we are a human-
bacterial superorganism with immense metabolic diversity and capacity.” The basis 
for this ambitious claim lies in the radical way in which metagenomics reconceives 
biological individuality. Traditionally, the individual mammalian organism – the 
horse or the human – has been the paradigm for both folk and scientific concepts of 
biological individuality.54 In spite of the fact that we mammals are rather atypical of 
living beings generally, this vision of individuality has structured both our biomedical 
science and our social practices. By using metagenomics to study human physiology, 
the HMP challenges these boundaries methodologically, and, by extension, the 
ontological categories we use to “carve nature at its joints”. Far from helping 
genomics realize the modern scientific project of reducing the ills of human 
individuals to their specific causes, metagenomics and the HMP seem poised to bring 
genomics to a post-modern understanding of the individual itself, as a pragmatic 
construction that we project upon on a much more complex system.55 Thus, the NRC 
concludes that: 
 
All plants and animals, including humans, can be considered 
superorganisms composed of many species, animal, bacterial, 
archaeal, and viral. Historically, the study of physiology has not 
focused on these host-associated microbial communities: 
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metagenomics offers an opportunity to understand their 
physiological role. .... The metagenome of these communities 
encodes physiological traits that humans have not had to evolve, 
including the ability to harvest nutrients and energy from food that 
would otherwise be lost because we lack the necessary digestive 
enzymes.56 
Discussion: Implications for human identity 
As the microbiomists acknowledge, “We are just beginning to realize the implications 
of being a superorganism, and the benefits of better knowing our intestinal 
inhabitants.”57 Indeed, one of the most tantalizing features of the promotional 
literature on human metagenomics is the suggestion by the heralds of the HMP that 
this research has revolutionary implications for our ordinary understanding of human 
nature and what it means to be a human being. In particular, two issues with 
significant ethical and social implications seem to be made more challenging by the 
superorganism conception.  
 
First, a superorganismic anthropology recalls the debates inspired by the philosopher 
Derek Parfit about the stability of the human individual over time, and the ethical 
implications of a transient conception of the self.58 Our conventional moral 
commitments to respect for personal autonomy, promise-keeping, truth-telling, and 
the rights and responsibilities that come with moral agency all assume that human 
individuals display a continuity of identity over time. Parfit’s critique of that 
continuity has created a philosophical industry in efforts either to rebut his views on 
behalf of ethics or to show how ethics can still apply across serial selves. If 
metagenomics suggests that our symbiotic microbial populations are integral to our 
identities as individual organisms and that they change over environments and time, 
this will bring Parfit’s view to the public in tangible ways, by suggesting that even the 
most ‘personalized’ medicine possible will face continuously shifting patients. As 
Dupré and O’Malley point out: 
 
A final crucial point about metaorganisms is that they are 
paradigmatically dynamic entities and therefore very clear 
illustrations of the ultimate necessity of a process-oriented approach 
to biological investigation. None of the entities that constitute 
organisms, or which organisms constitute, are static. Genomes, cells, 
and ecosystems are in constant interactive flux: subtly different in 
every iteration, but similar enough to constitute a distinctive 
process.59 
 
Mining the literature on the ethical implications of the loss of the ‘enduring self’ may 
be an important first step in preparing for the public reception of this paradigm shift. 
 
Second, the superorganism concept has dramatic implications for our notions of the 
integrity of the human species. The normative importance of ‘species integrity’ has 
been posited before within bioethics, to critique biomedical practices as varied as the 
fertilization of hamster ova with human spermatozoa, the transplantation of porcine 
organs into humans, the propagation of human stem cell lines in mice and the transfer 
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of human genes into bacteria. ‘Crossing species barriers’ sounds like trespassing, and 
the qualms it provokes have been explained in a variety of ways, from invocations of 
essentialistic or theological visions of human (and animal) nature to fears about risks 
of creating new forms of disease or ecological disruptions. Common across these 
claims, however, is the worry that biomedicine will undermine a given stability in the 
world by violating the categories that order it. Drawing in equal measure from 
Aristotelian essentialism and 19th Romantic sensibilities, this concern gives high 
normative weight to the biological kinds produced by the “Wisdom of Evolution” and 
their relative ranking in a hierarchical ‘great chain of being’. On this view, ‘splicing 
life’ in the creation of transgenic organisms, or interspecies tissue chimeras, or 
hybridized embryos – like importing alien species into an established ecosystem – is 
always dangerous enough to justify the use of the precautionary principle. For some, 
as Stout has pointed out, the creation of such “abominations” is also morally suspect, 
simply in its willful disregard for the natural order it crosses.60  
 
Anthropologists suggest that these concerns are often animated by the tacit roles that 
concepts of ‘purity’ and ‘pollution’ play in our cultural definitions of human bodily 
boundaries, health and disease.61 In situations that involve the integrity of the human 
species, like xenotransplantation, or the creation of man-machine ‘cyborgs’, this 
moral hazard can be explained as the danger of dehumanization: that polluting the 
constellation of traits that humans have inherited from our ancestors – our given 
‘human nature’ – with nonhuman attributes we will inevitably degrade the elements of 
human identity we find morally important, like human dignity, autonomy, and 
vulnerability. As Habermas puts it: 
 
What is at stake is a dedifferentiation, through biotechnology, of 
deep rooted categorical distinctions which we have as yet, in the 
description we give of ourselves, assumed to be invariant. This 
dedifferentiation might change our ethical self-understanding as a 
species in a way that could also affect our moral consciousness.62  
 
But meanwhile, we know that on and in the healthy human body microbial cells 
outnumber human cells 10 to one, and play an active role in maintaining our normal 
physiology. Now the HMP is underlining the significance of that role by suggesting 
that it may involve interactions at the genetic level as well, between human and 
bacterial cells. Our commensal bacteria, in essence, serve as crucial genomic 
extenders, much as they do in termites (whom they allow to digest wood). If so, the 
microbiologists argue, our basic concept of the human organism should be expanded 
to include our normal symbionts. Moreover, since our metagenomic profiles will vary 
among individuals and wax and wane over time, this science suggests that a canonical 
set of ‘human genes’ will never be available as a ground for human rights, or for 
determining when humans’ ‘species integrity’ has been breached.  
No one seems much concerned that we are all mixtures of many indigenous bacterial 
species and human cell lines. It neither undermines our fundamental rights, nor 
confers special moral status on bacteria. But it does seem as if concerns about the 
moral implications of blurring boundaries between the human species and non-human 
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organisms are animating those who are striving to protect our species’ ‘dignity and 
integrity’. If we are already superorganisms, those who are concerned are going to 
have to look further for an explanation for their anxieties. 
Conclusion: A new reductionism?  
In the glare of medicine's 19th century paradigms, it is hard to see what the metagenomic 
revolution might produce. It is clear, however, that better approaches to the 
understanding of complex systems will be required to translate its science into practical 
benefits and its message into public discourse. As the microbiomists say: 
 
The level of complexity required to take a dynamic ecological view 
of human microbiota is daunting, and will require collaborations 
among many disciplines including molecular biology, ecology, 
medicine, epidemiology and mathematics. To fully understand the 
mechanisms that drive community structure and function, microbiota 
must be examined over time to determine the dynamics of its 
processes, and over space to determine the interconnectedness of 
microbiota within an individual host and the range of microbiota 
among individuals.63  
 
In fact, if these complexities are neglected, the risk remains that the “metagenome” will 
fall prey to the same kinds of reductionism as individual genomic approaches. For 
example, Handelsman and her colleagues64 say that the historical importance of 
metagenomics to soil ecology lay in its ability to help microbial ecologists conceive of 
the entire DNA sequence of the environmental sample as a single genomic unit – the 
metagenome – enabling it to be cloned into BAC vectors which can be carried by E. 
coli. The BAC clones can then be screened for biological activity and novel gene 
products. But note that despite the ecological window dressing and air of holism, the 
tools of metagenomics take the complexity of the microbial ecosystem and reduce it 
to a single genetic sequence: the metagenome. If we draw a direct parallel, it would 
seem that to treat the gut microbiome as a genomic unit would downplay the role of 
ecological interactions and place a greater emphasis on gene product discovery. 
Therefore, while much of the discussion over the translational implications of 
metagenomics has centered on holistic notions such as restoring balance to the 
microbial ecosystem, if the entire system is reduced to its metagenome, it is prone to 
be turned into a tool for the discovery of traditional pharmacological agents, aimed at 
specific gene products and microbial variants.  
 
Along these lines, it is worth pointing out that one of the major discoveries of 
metagenome research has been an increased understanding of the metagenomic basis 
of anti-microbial resistance. For example, Coque and co-workers65 studied the 
metagenome of an entire hospital in Madrid over an 11-year period and found that 
bacterial resistance to several antimicrobial agents (due to the presence of extended 
spectrum -lactamases [ESBLs], a family of enzymes) persisted despite the ephemeral 
nature of the bacterial species responsible for producing these enzymes. They 
concluded that the genes coding for ESBLs were housed in transposable genetic 
elements as a minority gene population in the hospital metagenome. Residing in the 
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hospital metagenome, these ‘jumping genes’ persisted in a variety of bacterial species 
that themselves were not persistent, making certain bacterial infections difficult to 
treat.  
 
In light of this, it is ironic that one of the most promising directions for the translation 
of metagenome research is said to be the discovery of new antibiotics, a continuation 
of the war metaphor for host-bacterial interactions that many microbial ecologists had 
been working to overturn While this is far from the only direction that translational 
metagenomics research might go (in fact, metagenomics has also been instrumental in 
discovering novel genes conferring antimicrobial resistance66) it certainly is one area 
receiving much attention, particularly because of its commercial prospects.  
To the extent that the metaphors of metagenomics accurately capture the philosophical 
implications of the science, translating the message of microbiomics will require tools 
for talking about issues of human identity, health and disease, and genetic causation in 
ways that run counter to the messages that genomics has taught us in the past. For this 
form of “translational genomic research,” it may be more important than ever for the 
many collaborators involved to include not just the list above, but also those disciplines 
that specialize in capturing what can otherwise be lost in translation in public discourse: 
the social sciences, the humanities, and the arts.  
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